Cargando…
Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification
β(2)-agonists are a class of synthetic sympathomimetic drugs with acute poisoning effects if consumed as residues in foods. To improve the efficiency of sample preparation and to overcome matrix-dependent signal suppression in the quantitative analysis of four β(2)-agonists (clenbuterol, ractopamine...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004211/ https://www.ncbi.nlm.nih.gov/pubmed/36903285 http://dx.doi.org/10.3390/molecules28052039 |
_version_ | 1784904776767504384 |
---|---|
author | Cai, Chenggang Xiang, Yannan Tian, Siyi Hu, Zhongce Hu, Zhengyan Ma, Bingjie Wu, Pinggu |
author_facet | Cai, Chenggang Xiang, Yannan Tian, Siyi Hu, Zhongce Hu, Zhengyan Ma, Bingjie Wu, Pinggu |
author_sort | Cai, Chenggang |
collection | PubMed |
description | β(2)-agonists are a class of synthetic sympathomimetic drugs with acute poisoning effects if consumed as residues in foods. To improve the efficiency of sample preparation and to overcome matrix-dependent signal suppression in the quantitative analysis of four β(2)-agonists (clenbuterol, ractopamine, salbutamol, and terbutaline) residues in fermented ham, an enzyme digestion coupled cation exchange purification method for sample preparation was established using ultra-high performance liquid chromatography and tandem mass spectrometry (UHPLC-MS/MS). Enzymatic digests were subject to cleanup treatment on three different solid phase extraction (SPE) columns and a polymer-based strong cation resin (SCR) cartridge containing sulfonic resin was found to be optimal compared with silica-based sulfonic acid and polymer sulfonic acid resins based SPEs. The analytes were investigated over the linear range of 0.5 to 10.0 μg/kg with recovery rates of 76.0–102.0%, and a relative standard deviation of 1.8–13.3% (n = 6). The limit of detection (LOD) and the limit of quantification (LOQ) were 0.1 μg/kg and 0.3 μg/kg, respectively. This newly developed method was applied to the detection of β(2)-agonist residues in 50 commercial ham products and only one sample was found to contain β(2)-agonist residues (clenbuterol at 15.2 µg/kg). |
format | Online Article Text |
id | pubmed-10004211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100042112023-03-11 Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification Cai, Chenggang Xiang, Yannan Tian, Siyi Hu, Zhongce Hu, Zhengyan Ma, Bingjie Wu, Pinggu Molecules Article β(2)-agonists are a class of synthetic sympathomimetic drugs with acute poisoning effects if consumed as residues in foods. To improve the efficiency of sample preparation and to overcome matrix-dependent signal suppression in the quantitative analysis of four β(2)-agonists (clenbuterol, ractopamine, salbutamol, and terbutaline) residues in fermented ham, an enzyme digestion coupled cation exchange purification method for sample preparation was established using ultra-high performance liquid chromatography and tandem mass spectrometry (UHPLC-MS/MS). Enzymatic digests were subject to cleanup treatment on three different solid phase extraction (SPE) columns and a polymer-based strong cation resin (SCR) cartridge containing sulfonic resin was found to be optimal compared with silica-based sulfonic acid and polymer sulfonic acid resins based SPEs. The analytes were investigated over the linear range of 0.5 to 10.0 μg/kg with recovery rates of 76.0–102.0%, and a relative standard deviation of 1.8–13.3% (n = 6). The limit of detection (LOD) and the limit of quantification (LOQ) were 0.1 μg/kg and 0.3 μg/kg, respectively. This newly developed method was applied to the detection of β(2)-agonist residues in 50 commercial ham products and only one sample was found to contain β(2)-agonist residues (clenbuterol at 15.2 µg/kg). MDPI 2023-02-21 /pmc/articles/PMC10004211/ /pubmed/36903285 http://dx.doi.org/10.3390/molecules28052039 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cai, Chenggang Xiang, Yannan Tian, Siyi Hu, Zhongce Hu, Zhengyan Ma, Bingjie Wu, Pinggu Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title | Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title_full | Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title_fullStr | Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title_full_unstemmed | Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title_short | Determination of β(2)-Agonist Residues in Fermented Ham Using UHPLC-MS/MS after Enzymatic Digestion and Sulfonic Resin Solid Phase Purification |
title_sort | determination of β(2)-agonist residues in fermented ham using uhplc-ms/ms after enzymatic digestion and sulfonic resin solid phase purification |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004211/ https://www.ncbi.nlm.nih.gov/pubmed/36903285 http://dx.doi.org/10.3390/molecules28052039 |
work_keys_str_mv | AT caichenggang determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT xiangyannan determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT tiansiyi determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT huzhongce determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT huzhengyan determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT mabingjie determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification AT wupinggu determinationofb2agonistresiduesinfermentedhamusinguhplcmsmsafterenzymaticdigestionandsulfonicresinsolidphasepurification |